Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$648000.0.

  • Orthopediatrics' Other Non Operating Income rose 7993.81% to -$648000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 33078.48%. This contributed to the annual value of -$3.2 million for FY2024, which is 24285.71% down from last year.
  • As of Q3 2025, Orthopediatrics' Other Non Operating Income stood at -$648000.0, which was up 7993.81% from $4.7 million recorded in Q2 2025.
  • Orthopediatrics' Other Non Operating Income's 5-year high stood at $4.7 million during Q2 2025, with a 5-year trough of -$3.2 million in Q3 2024.
  • Moreover, its 5-year median value for Other Non Operating Income was $213500.0 (2021), whereas its average is $218222.2.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 51041.93% in 2024, then soared by 675000.0% in 2025.
  • Over the past 5 years, Orthopediatrics' Other Non Operating Income (Quarter) stood at $281000.0 in 2021, then tumbled by 145.55% to -$128000.0 in 2022, then soared by 767.19% to $854000.0 in 2023, then crashed by 478.22% to -$3.2 million in 2024, then skyrocketed by 79.94% to -$648000.0 in 2025.
  • Its last three reported values are -$648000.0 in Q3 2025, $4.7 million for Q2 2025, and $1.6 million during Q1 2025.